Investment Manager Bets PTCT: Big Bet on PTCT Stock
A top institutional trader doubled down on PTCT, adding thousands of shares in a high-conviction move. This analysis ...
Understanding the ideal retirement planning timeline is crucial for securing your future. Learn how to effectively plan your retirement.
13,883 articlesA top institutional trader doubled down on PTCT, adding thousands of shares in a high-conviction move. This analysis ...
Oscar Health is betting on a 2026 profitability turnaround after a challenging Q4 2025, highlighting AI efficiency, h...
Lucid Group shares fell about 6% as investors grilled the company after a mixed Investor Day, with widening losses an...
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Crypto.com cuts around staff by about 12%, eliminating roughly 180 roles as it refocuses on AI-enabled enterprise ser...
A letter allegedly from Sam Bankman-Fried is under intense scrutiny as prosecutors question its authenticity. Amid fa...
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
A prominent Trump-backed bitcoin mining venture reported a heavy Q1 loss, triggering a notable slide in its shares. T...
The Department of Homeland Security is requesting $7.5 million to develop wearable facial-recognition glasses for ICE...
Standard Chartered is moving to absorb Zodia Custody's crypto operations, extending its digital-asset platform. The d...
Jaguar (JAGX) 2025 earnings show a company shifting from product-driven revenue to licensing cash. This piece breaks ...
New York moves toward banning potassium bromate in flour, potentially altering crusts and prices for thousands of piz...